MedPath

Optical spectroscopy as a novel tool in the diagnostics of skin neoplasms.

Conditions
Skin cancer
skin neoplasms
10040900
Registration Number
NL-OMON38657
Lead Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
105
Inclusion Criteria

* Age 18 or over
* Clinically suspect lesion; either actinic keratosis, squamous cell carcinoma or basal cell carcinoma
* No prior treatment for the lesion
* Good understanding of Dutch or English;Additional inclusion criterion for biopsy
* Lesion size * 2 cm

Exclusion Criteria

* Prior treatment of the lesion
* Serious other illness

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Parameters that will be measured are: blood oxygen saturation, blood volume<br /><br>fraction, vessel diameter, melanin, beta-carotene and bilirubin concentration,<br /><br>autofluorescence and reduced scattering coefficient. Every parameter will be<br /><br>investigated for its difference between lesions and capability to predict the<br /><br>nature of the lesion. As a control, sun exposed or normal skin of the same<br /><br>subject is measured as well.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Nanostructural changes of the skin will be evaluated in 15 biopsies (5 per<br /><br>lesion type) using electron microscopy. Biopsy will be performed on the same<br /><br>site as the measurement. Electron microscopy of these biopsies will be related<br /><br>to the spectroscopic data.</p><br>
© Copyright 2025. All Rights Reserved by MedPath